Qiagen Registers $127.1M in Employee Stock Options | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen on Thursday filed for the registration of up to $127.1 million in shares in connection to stock options being offered to employees.

The company filed a registration for 9 million shares at a proposed maximum offering price of $14.12 in a Form S-8 filed with the US Securities and Exchange Commission.

The price was based on the average of the high and low sale prices of Qiagen's stock as of Nov. 15, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.